Abarca Health Launches Darwin H/I, Advancing the Continuous Evolution of Its Healthcare Intelligence

Oct 22, 2026

Guided by four tenets and a clear point of view on AI, Darwin H/I builds on a foundation of early predictive models and automation to deliver. An evolving suite of solutions built for pharmacy benefits, with Darwin Context, Darwin PAth, and Charlie today. And, in the future, Darwin Companion and Darwin Predict.

SAN JUAN, P.R.

Abarca Health today launched Darwin H/I

Darwin Healthcare Intelligence, the next evolution of Darwin, its pharmacy benefit operating system. Darwin H/I embeds Healthcare Intelligence natively across the platform, grounded in the data Darwin already processes, connected to the workflows health plans, providers, and members already use, and explainable at every decision point.

The launch is not Abarca’s first venture into applied AI. It is the latest step in a longer arc. For years, ahead of the industry’s current AI moment, Abarca has quietly built predictive intelligence and automation into Darwin. Darwin Target leveraged machine learning models before the generative AI explosion. Darwin Automate used robotic process automation (RPA) to achieve efficiencies across claims and operations. These early proof points for the Darwin H/I vision reinforced that Abarca’s approach to AI was never about chasing the latest trend. Instead, it is about solving real problems for health plans, providers, and patients.

Since then, that foundation has kept evolving. Darwin Source maps Darwin’s source code in a way that enables engineers to build better AI solutions. Darwin Tracer tracks claims through multiple decisions and modules, so the logic behind each outcome can be documented and explained. Today, Abarca’s three newest solutions show what this evolution delivers in practice. Darwin Context, the platform’s intelligent information layer, connects Abarca’s data across all domains so that users and apps alike can understand any relevant code, configuration or documentation to make more informed decisions. Charlie, Darwin’s assistant, gives every user an easier interface to ask questions, simulate scenarios, and take action. Darwin PAth delivers efficiencies across the prior authorization and coverage determination process, enabling the evolution of Abarca’s Better Care Program to deliver savings while keeping clinicians in the loop to make final decisions.

Abarca CEO Jason Borschow presents Darwin H/I to employees, seated in front of an Abarca backdrop as the team looks on.

 

The distinction Abarca is drawing is architectural, not cosmetic. Rather than layering AI features on top of existing apps, Darwin H/I is built directly into Darwin’s core operating design, so intelligence is the default across the platform rather than an add-on to it. That approach rests on four tenets that define Abarca’s point of view on AI:

  • Transparency, so every decision is visible and traceable
  • Humanity, so technology supports the people behind every claim rather than reducing them to a transaction
  • Boldness, to challenge assumptions that have held pharmacy benefits back
  • Accountability, so every recommendation can be explained and every outcome evaluated

“Darwin H/I is built on the models and automation we’ve been running quietly inside Darwin for years,” said Jason Borschow, Chief Executive Officer of Abarca Health. “But the beginning is not the story. The story is what comes next, with a platform where intelligence is transparent, accountable, and built into every decision, not bolted on top of it. We didn’t create Healthcare Revolution Partners to keep pace with this industry. We built it to accelerate the revolution already underway, and Darwin H/I is how we power this revolution, today and for years to come.”

Darwin Companion, the evolution of Abarca’s pharmacy portal, and Darwin Predict, a predictive drug trend management model built on Abarca’s proprietary data, are expected to be released in the near future. Because AI continues to change, Abarca expects its solutions to change with it: some will evolve into new versions, and others will be superseded by future iterations of Darwin H/I.

“Health plans don’t need another AI feature bolted onto a legacy system. They need intelligence woven natively into core platforms that drive growth and efficiency,” added Borschow. “This next evolution of Darwin into the Healthcare Intelligence era is accelerating the revolution of pharmacy benefit management.”

Two men seated on stools in front of an Abarca backdrop during the Darwin H/I presentation, one speaking while the other listens.

The launch comes as Abarca Health and LucyRx operate together under Healthcare Revolution Partners. Together, they serve more than 9 million members across commercial and government markets. Darwin H/I underpins that combined platform. In fact, Abarca expects it to be central to how Healthcare Revolution Partners differentiates its offering and serves clients.

This matters because more health plans are looking for a PBM that offers:

  • Smarter prior authorization and clinical workflows
  • Decisions they can trace and explain
  • Lower administrative burden
  • Earlier visibility into cost drivers
  • Flexible and, connected technology

For more information about Darwin H/I, visit meetdarwin.com

Abarca Health launches Darwin H/I, advancing its Healthcare Intelligence, shown with screens from the Darwin platform.

____

About Abarca Health

At Abarca, we see a future in which healthcare is seamless and personalized, and we are working every day to make it a reality for the people and organizations we serve. We are starting with prescriptions, the frontline of healthcare. But by leveraging Darwin, our smarter technology, straightforward business approach, and a team driven to innovate and find a better way in everything we do. We are enabling a broader healthcare revolution.

Abarca manages $14B in annual drug spend and serves clients across the United States, including those that have achieved a 5-Star Medicare Part D rating. Following its strategic combination with LucyRx, Abarca now operates as a wholly owned subsidiary of Healthcare Revolution Partners. Together, Abarca and LucyRx serve more than 9 million members across commercial and government markets. With 20 years of unstoppable drive, we continue to build a better way in healthcare. Visit abarcahealth.com for more information.

Last Updated on October 23, 2026

Our Journey

Be part of the future of healthcare

We are on a mission to transform the prescription experience and enable a broader healthcare revolution. Join us!

Contact Us